dc.creatorAguilera, Bernardo
dc.creatorBeca, Juan Pablo
dc.date.accessioned2019-03-18T12:03:21Z
dc.date.available2019-03-18T12:03:21Z
dc.date.created2019-03-18T12:03:21Z
dc.date.issued2018
dc.identifierRevista Medica de Chile, Volumen 146, Issue 4, 2018, Pages 518-522
dc.identifier07176163
dc.identifier00349887
dc.identifierhttps://repositorio.uchile.cl/handle/2250/167601
dc.description.abstract© 2018, Sociedad Medica de Santiago. All rights reserved. When prescribing a treatment, the physician should give truthful information about the likely benefits and the potential adverse effects, allowing the patient to make an autonomous decision about whether to take the treatment. However, the mere expectation of adverse effects may precipitate the corresponding symptoms. This is called “nocebo effect”, which in contrast to the placebo effect, can lead to harm to the patient due to psychological factors. Nocebo effects are common and clinically significant, although often unnoticed. This situation generates conflicts in medical ethics guiding principles, namely the moral obligation to disclose all possible effects of the prescribed drug as opposed to the duty of avoiding the harm of side effects that are likely to occur in a case. In other words, the physician faces a dilemma between the due respect for autonomy and the duty of non-maleficence. This article reflects about this confl
dc.languageen
dc.publisherSociedad Medica de Santiago
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceRevista Medica de Chile
dc.subjectBioethics
dc.subjectDisclosure
dc.subjectEthics
dc.subjectInformed consent
dc.subjectMedical
dc.subjectNocebo effect
dc.subjectTruth disclosure
dc.titlePartial disclosure of information in the presence of presumable nocebo effects: An ethical analysis Análisis ético de la entrega parcial de información al paciente para prevenir efectos nocebo
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución